Entering text into the input field will update the search result below

Mylan says rumored Teva marriage would not makes sense

Apr. 20, 2015 11:20 AM ETViatris Inc. (VTRS) StockTEVA, PRGO, VTRSBy: Douglas W. House, SA News Editor
  • Generics firm Mylan (MYL -2.9%) admits that it considered a merger with Teva Pharmaceuticals Industries (TEVA -1.4%) but such a deal would be "without sound industrial logic." CEO Robert Coury says, "We believe that it is unlikely that any such combination could obtain antitrust regulatory clearances. Mylan is fully committed to its stand-alone strategy, including its proposal to acquire Perrigo, and today's speculation has no impact whatsoever on this strategy."
  • Many observers believe that Mylan's unsolicited $29B bid for Perrigo (PRGO -0.7%) was a defensive tactic to make itself less attractive to Teva.
  • Teva has not disclosed its intentions as of yet.
  • Previously: Teva reportedly weighing bid for Mylan; shares jump (April 17)

Recommended For You

More Trending News

About VTRS Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
VTRS--
Viatris Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.